40 reports

  • TREATMENT GUIDELINES FOR BIPOLAR DISORDER
  • RISK FACTORS AND COMORBIDITIES FOR BIPOLAR DISORDER

PharmaPoint: Bipolar Disorder - Global Drug Forecast and Market Analysis to 2024 Summary Bipolar disorder is a mental disorder characterized by periods of mania and depression. The frequency, severity, and pattern of these episodes can vary considerably over time and between individuals, making bipolar disorder one of...

  • Bipolar Disorder
  • World
  • Market Size
  • AstraZeneca PLC
  • Otsuka Pharmaceutical Co., Ltd.

Global Bipolar Disorder Epidemiology and Patient Flow Analysis - 2017 ##.

  • Bipolar Disorder
  • France
  • United States
  • World
  • Forecast

Bipolar Disorder (Manic Depression) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018 ##.

  • Bipolar Disorder
  • United States
  • World
  • Demand
  • Product Initiative
  • 5.4.1 DIAGNOSED BIPOLAR DISORDER PATIENTS
  • PROVIDES A SWOT ANALYSIS OF ALLERGAN IN THE BIPOLAR DISORDER MARKET.

Bipolar Disorder - Current and Future Players Summary GlobalData has released its pharma report, “Bipolar Disorder - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Bipolar Disorder Market. The report identifies and analyses...

  • Bipolar Disorder
  • Allergan plc
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • Janssen Biotech, Inc.
  • RISK FACTORS AND COMORBIDITIES FOR BIPOLAR DISORDER
  • 3.5 EPIDEMIOLOGICAL FORECAST OF BIPOLAR DISORDER (2014-2024)

EpiCast Report: Bipolar Disorder - Epidemiology Forecast to 2024 Summary Bipolar disorder, also known as bipolar depression or manic depression, is a psychological disorder that presents with severe shifts in mood from one extreme to another. The mood swings occur in a cyclic or periodic pattern that includes feelings...

  • Bipolar Disorder
  • Japan
  • United States
  • World
  • Forecast
  • TREATMENT GUIDELINES FOR BIPOLAR DISORDER
  • THE ETIOLOGY AND PATHOPHYSIOLOGY OF BIPOLAR DISORDERS

Bipolar Disorder - 5EU Drug Forecast and Market Analysis to 2024 Summary Bipolar disorder is a mental disorder characterized by periods of mania and depression. The frequency, severity, and pattern of these episodes can vary considerably over time and between individuals, making bipolar disorder one of the most challenging...

  • Bipolar Disorder
  • World
  • Forecast
  • Eli Lilly & Co.
  • Otsuka Pharmaceutical Co., Ltd.
  • TREATMENT GUIDELINES FOR BIPOLAR DISORDER
  • THE ETIOLOGY AND PATHOPHYSIOLOGY OF BIPOLAR DISORDERS

Bipolar Disorder - US Drug Forecast and Market Analysis to 2024 Summary Bipolar disorder is a mental disorder characterized by periods of mania and depression. The frequency, severity, and pattern of these episodes can vary considerably over time and between individuals, making bipolar disorder one of the most challenging...

  • Bipolar Disorder
  • World
  • Forecast
  • Eli Lilly & Co.
  • Otsuka Pharmaceutical Co., Ltd.
  • THE ETIOLOGY AND PATHOPHYSIOLOGY OF BIPOLAR DISORDERS
  • TREATMENT GUIDELINES FOR BIPOLAR DISORDER

Bipolar Disorder - Canada Drug Forecast and Market Analysis to 2024 Summary Bipolar disorder is a mental disorder characterized by periods of mania and depression. The frequency, severity, and pattern of these episodes can vary considerably over time and between individuals, making bipolar disorder one of the most challenging...

  • Bipolar Disorder
  • World
  • Forecast
  • Eli Lilly & Co.
  • Otsuka Pharmaceutical Co., Ltd.
  • THE ETIOLOGY AND PATHOPHYSIOLOGY OF BIPOLAR DISORDERS
  • TREATMENT GUIDELINES FOR BIPOLAR DISORDER

Bipolar Disorder - Japan Drug Forecast and Market Analysis to 2024 Summary Bipolar disorder is a mental disorder characterized by periods of mania and depression. The frequency, severity, and pattern of these episodes can vary considerably over time and between individuals, making bipolar disorder one of the most challenging...

  • Bipolar Disorder
  • World
  • Forecast
  • Eli Lilly & Co.
  • Otsuka Pharmaceutical Co., Ltd.

Additionally, the drugs in the bipolar disorder market are bound to face intense competition from generic drugs, as treatment options for bipolar disorder.

  • Bipolar Disorder
  • Mental Health
  • United States
  • Forecast
  • Market Size

& nbsp; Forecasted growth in the total prevalence of bipolar I disorder and bipolar II disorder will be driven by demographics.

  • Bipolar Disorder
  • European Union
  • Japan
  • United States
  • Demand
  • CYCLICAL NATURE OF BIPOLAR DISORDER
  • Treatment: Bipolar Disorder

Generic dominance will prevent the growth of the bipolar disorder market, and few pipeline candidates show promise to completely reverse this trend. This report addresses the following questions: - What are the key events shaping the bipolar disorder market dynamics over 2014–23? - Which segments of the market provide...

  • Bipolar Disorder
  • North America
  • United States
  • AstraZeneca PLC
  • Eli Lilly & Co.

Bipolar Disorder (Manic Depression) - Epidemiology Forecast to 2027 ##.

  • Bipolar Disorder
  • France
  • Germany
  • Italy
  • Spain

Bipolar Disorder Phase ## Clinical Trials, 2016 ##.

  • Bipolar Disorder
  • France
  • United States
  • Market Shares
  • Market Size

Bipolar Disorder (Manic Depression) - Market Insight, Epidemiology and Market Forecast - 2027 ##.

  • Bipolar Disorder
  • Depression
  • Mental Health
  • United States
  • Market Shares

Europe Bipolar Disorder Epidemiology and Patient Flow Analysis - 2017 ##.

  • Bipolar Disorder
  • Europe
  • France
  • Germany
  • Forecast

Bipolar Disorder Phase ## Clinical Trials, 2016 ##.

  • Bipolar Disorder
  • France
  • Germany
  • Market Shares
  • Market Size

Bipolar Disorder Phase ## Clinical Trials, 2016 ##.

  • Bipolar Disorder
  • Mental Health
  • Japan
  • Market Shares
  • Market Size

Bipolar Disorder Phase ## Clinical Trials, 2016 ##.

  • Bipolar Disorder
  • Mental Health
  • United States
  • Market Shares
  • Market Size

Bipolar Disorder Phase ## Clinical Trials, 2016 ##.

  • Bipolar Disorder
  • Mental Health
  • United Kingdom
  • Market Shares
  • Market Size

Bipolar Disorder Phase ## Clinical Trials, 2016 ##.

  • Bipolar Disorder
  • Mental Health
  • Italy
  • Market Shares
  • Market Size

Bipolar Disorder Phase ## Clinical Trials, 2016 ##.

  • Bipolar Disorder
  • Mental Health
  • France
  • Market Shares
  • Market Size

Bipolar Disorder Phase ## Clinical Trials, 2016 ##.

  • Bipolar Disorder
  • Mental Health
  • Germany
  • Market Shares
  • Market Size

Bipolar Disorder Phase ## Clinical Trials, 2016 ##.

  • Bipolar Disorder
  • Mental Health
  • Spain
  • Market Shares
  • Market Size
  • SIGNS AND SYMPTOMS OF BIPOLAR DISORDER
  • INCREASE IN PREVALENCE OF BIPOLAR DISORDER

About bipolar disorder therapeutics Bipolar disorder is a psychological disorder characterized by intermittent mood swings. The individual suffering with this disorder experiences extreme poles of either mania or depression or both. The disorder severely affects the personal, social, and professional life of an individual. The symptoms...

  • Bipolar Disorder
  • Allergan plc
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • Janssen Biotech, Inc.

Drug Overview: Risperdal Consta TABLE OF CONTENTS ## OVERVIEW ## Drug Overview ## Product Profiles ## Risperdal Consta : Bipolar disorder ## Risperdal Consta : Schizophrenia LIST OF FIGURES ## Figure ##: Risperdal Consta for bipolar disorder – SWOT analysis

  • Bipolar Disorder
  • European Union
  • Japan
  • United States
  • Market Description

Drug Overview: Zyprexa

8770 10000 7800

Drug Overview: Zyprexa TABLE OF CONTENTS ## OVERVIEW ## Drug Overview ## Product Profiles ## Zyprexa : Bipolar disorder ## Zyprexa : Schizophrenia LIST OF FIGURES ## Figure ##: Zyprexa for bipolar disorder – SWOT analysis ## Figure ##: Datamonitor Healthcare’

  • Bipolar Disorder
  • Psychotic Disorder
  • European Union
  • Japan
  • United States
  • TOP COMPANIES PARTICIPATING IN BIPOLAR DISORDER (MANIC DEPRESSION) THERAPEUTICS CLINICAL TRIALS
  • IN ASIA-PACIFIC REGION, INDIA HAS THE HIGHEST NUMBER OF BIPOLAR DISORDER (MANIC DEPRESSION) CLINICAL TRIALS, AS OF APRIL 2017.

Bipolar Disorder (Manic Depression) Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Bipolar Disorder (Manic Depression) Global Clinical Trials Review, H1, 2017" provides an overview of Bipolar Disorder (Manic Depression) clinical trials scenario. This report provides top line data relating...

  • Bipolar Disorder
  • Clinical Trial
  • Depression
  • Neurology
  • World
  • Bipolar Disorder (Manic Depression) Overview
  • SMALL MOLECULE FOR BIPOLAR DISORDER - DRUG PROFILE

Bipolar Disorder (Manic Depression) - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bipolar Disorder (Manic Depression) – Pipeline Review, H2 2016, provides an overview of the Bipolar Disorder (Manic Depression) (Central Nervous System) pipeline landscape. Bipolar...

  • Bipolar Disorder
  • United States
  • Company
  • Product Initiative
  • Intra-Cellular Therapies, Inc.

Bipolar Disorder (Manic Depression) Ongoing Global Clinical Trials Analysis and Outlook ## Table of Contents ##. ## List of Figures ##. ## List of Tables ## Key Findings, 2018 ##. ## Snapshot ##. ## Overview of Bipolar Disorder (Manic Depression) Trials ## Clinical Tria

  • Bipolar Disorder
  • Depression
  • Mental Health
  • Pathology